US Stock MarketDetailed Quotes
XBIT XBiotech
- 6.830
- +0.210+3.17%
Close Nov 22 16:00 ET
- 6.830
- 0.0000.00%
Post 16:02 ET
208.20MMarket Cap-6324P/E (TTM)
7.030High6.535Low37.41KVolume6.660Open6.620Pre Close254.63KTurnover0.19%Turnover RatioLossP/E (Static)30.48MShares9.96052wk High1.08P/B135.56MFloat Cap3.60052wk Low--Dividend TTM19.85MShs Float28.003Historical High--Div YieldTTM7.48%Amplitude1.835Historical Low6.806Avg Price1Lot Size
XBiotech Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -293.07%-5.85M | -26.44%-11.38M | -49.79%-7.2M | -26.32%-18.73M | -8.50%-3.43M | -29.30%-1.49M | -67.01%-9M | 6.15%-4.81M | -121.35%-14.82M | -79.87%-3.16M |
| Net income from continuing operations | 31.90%-5.02M | -48.78%-13.01M | -162.11%-10M | 25.36%-24.56M | -44.71%-4.64M | 41.82%-7.36M | 24.92%-8.74M | 29.27%-3.82M | -88.93%-32.9M | 50.47%-3.2M |
| Operating gains losses | -166.38%-707K | 141.72%554K | 513.05%1.58M | -167.61%-1.89M | 59.34%-1.25M | -78.16%1.07M | ---1.33M | ---383K | --2.8M | ---3.07M |
| Depreciation and amortization | 1.62%439K | 0.00%435K | -2.48%432K | -33.28%1.74M | -2.03%434K | -41.14%432K | -40.17%435K | -37.61%443K | -1.28%2.61M | -36.89%443K |
| Change In working capital | -127.07%-927K | 194.93%262K | 123.05%405K | -64.22%2.72M | -18.34%1.33M | -28.18%3.43M | -108.93%-276K | 6.84%-1.76M | -90.47%7.6M | -38.73%1.63M |
| -Change in receivables | -95.04%122K | 94.51%-48K | 99.13%-10K | -88.71%829K | -63.68%397K | -74.67%2.46M | 53.92%-875K | 26.62%-1.16M | 323.54%7.34M | -26.50%1.09M |
| -Change in prepaid assets | 2.90%71K | 81.97%-44K | -202.91%-312K | -147.90%-160K | 490.00%118K | 190.79%69K | -377.27%-244K | -134.11%-103K | 194.89%334K | 103.58%20K |
| -Change in payables and accrued expense | -225.28%-1.12M | -58.01%354K | 265.23%727K | 184.62%2.11M | 46.57%812K | 119.76%894K | -84.17%843K | 28.34%-440K | 365.59%741K | 345.13%554K |
| -Change in other working capital | ---- | ---- | ---- | 92.76%-59K | --0 | --0 | --0 | ---59K | -101.04%-815K | -102.15%-42K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -293.07%-5.85M | -26.44%-11.38M | -49.79%-7.2M | -26.32%-18.73M | -8.50%-3.43M | -29.30%-1.49M | -67.01%-9M | 6.15%-4.81M | -121.35%-14.82M | -79.87%-3.16M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -100.55%-338K | -201.44%-627K | -4,150.00%-255K | 196.25%61.5M | 97.06%-115K | 203.49%61.83M | -153.66%-208K | 96.27%-6K | -1,712.54%-63.89M | -720.80%-3.91M |
| Net PPE purchase and sale | -924.24%-338K | -201.44%-627K | -4,150.00%-255K | 38.12%-362K | 12.88%-115K | 84.29%-33K | -153.66%-208K | 96.27%-6K | 83.40%-585K | 72.27%-132K |
| Net investment purchase and sale | ---- | ---- | ---- | 197.71%61.86M | --0 | ---- | ---- | ---- | ---63.31M | ---3.78M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -100.55%-338K | -201.44%-627K | -4,150.00%-255K | 196.25%61.5M | 97.06%-115K | 203.49%61.83M | -153.66%-208K | 96.27%-6K | -1,712.54%-63.89M | -720.80%-3.91M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 1,180.00%64K | 442.86%48K | 10.06M | -9K | 0 | 5K | -14K | 0 | 0 | 0 |
| Net issuance payments of debt | --0 | --0 | --10M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net common stock issuance | ---- | ---- | --55K | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Proceeds from stock option exercised by employees | 1,180.00%64K | ---- | ---- | --5K | --0 | --5K | ---- | ---- | --0 | --0 |
| Net other financing activities | ---- | ---- | ---- | ---14K | --0 | --0 | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 1,180.00%64K | 442.86%48K | --10.06M | ---9K | --0 | --5K | ---14K | --0 | --0 | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 31.48%188.53M | 31.84%201.04M | 27.16%200.02M | -33.62%157.31M | 25.92%202.19M | -36.49%143.39M | -34.22%152.48M | -33.62%157.31M | -0.16%236.98M | -32.78%160.57M |
| Current changes in cash | -110.14%-6.12M | -29.68%-11.96M | 153.97%2.6M | 154.33%42.76M | 49.82%-3.55M | 199.10%60.34M | -68.57%-9.22M | 8.89%-4.81M | -7,134.93%-78.72M | -221.12%-7.07M |
| Effect of exchange rate changes | 145.79%707K | -539.68%-554K | -19,675.00%-1.58M | 95.21%-46K | -63.77%1.38M | 64.37%-1.54M | 122.54%126K | -106.56%-8K | -236.31%-961K | 1,136.69%3.81M |
| End cash Position | -9.43%183.12M | 31.48%188.53M | 31.84%201.04M | 27.16%200.02M | 27.16%200.02M | 25.92%202.19M | -36.49%143.39M | -34.22%152.48M | -33.62%157.31M | -33.62%157.31M |
| Free cash flow | -306.78%-6.18M | -30.40%-12M | -54.90%-7.46M | -23.87%-19.09M | -7.65%-3.55M | -11.76%-1.52M | -68.31%-9.21M | 8.89%-4.81M | -123.38%-15.41M | -47.47%-3.3M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data